I-MAB SPONS.ADS/1 -0001
Healthcare · EUR · F
Price
€1.506
Cap
€533.68M
Earnings
—
30d Trend
-30.1%
67% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 36×Macro 0.99 (−1%)=36
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate I-MAB SPONS.ADS/1 -0001 at 36/100 — a WEAK reading on the Brain47 Signal. The strongest factor is momentum at 53/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-20.4%
3 MONTHS
-43.0%
12 MONTHS
+48.4%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Momentum (53) and Technical (45) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 67%. I classify this as a speculative position — elevated volatility at 67% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.